Observational studyAnaesthesiology intensive therapy2025

Is an extended dose of subcutaneous nadroparin anticoagulation equally safe and feasible compared to unfractionated heparin anticoagulation during extracorporeal membrane oxygenation in critically ill COVID-19 patients?

Paweł Piwowarczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.